Tokyo Tape
Sign in
← Stella Pharma

Annual report

4888.TEDINET S100OKWQ
Period2021-04-01 → 2022-03-31
Filed2022-06-30
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 70
MetricValuePeriodScopeSource row
Revenue¥100m2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥206m2020-04-01 → 2021-03-31StandaloneNet sales
Operating income−¥742m2021-04-01 → 2022-03-31StandaloneOperating income
Operating income−¥681m2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income−¥764m2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income−¥656m2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income−¥959m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥856m2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥1.1bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥764m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax−¥656m2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income−¥768m2021-04-01 → 2022-03-31StandaloneProfit loss
Net income−¥659m2020-04-01 → 2021-03-31StandaloneProfit loss
Net income−¥962m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income−¥859m2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income−¥1.1bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥4.7bnat 2022-03-31StandaloneAssets
Total assets¥2.0bnat 2021-03-31StandaloneAssets
Total assets¥2.7bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.6bnat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥4.4bnat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥1.6bnat 2022-03-31StandaloneLiabilities
Total liabilities¥1.8bnat 2021-03-31StandaloneLiabilities
Net assets / equity¥3.1bnat 2022-03-31StandaloneNet assets
Net assets / equity¥231mat 2021-03-31StandaloneNet assets
Net assets / equity¥690mat 2020-03-31dStandaloneNet assets
Net assets / equity¥1.7bnat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥2.5bnat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.3bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥1.3bnat 2021-03-31StandaloneCash and deposits
Cash & equivalents¥3.2bnat 2022-03-31StandaloneCash and cash equivalents
Cash & equivalents¥838mat 2021-03-31StandaloneCash and cash equivalents
Cash & equivalents¥2.0bnat 2020-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2019-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.1bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥773m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥914m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥771m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥351m2021-04-01 → 2022-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥23m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥1.6bn2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15m2018-04-01 → 2019-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥3.8bn2021-04-01 → 2022-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥332m2020-04-01 → 2021-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥69m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-27.342021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-32.92020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-61.682019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.282018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-8,137.762017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥107.39at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥11.46at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥34.57at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-142.57at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥-7,629.02at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio65.3%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio11.3%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio25.9%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio45.6%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio56.5%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
Shares issued28,676,100at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued20,137,400at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued19,960,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued129,600at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued129,600at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees43at 2022-03-31StandaloneNumber of employees
Employees43at 2021-03-31StandaloneNumber of employees
Employees42at 2020-03-31dStandaloneNumber of employees
Employees36at 2019-03-31dStandaloneNumber of employees
Employees32at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 755
ItemContextValueUnit
Net cash provided by used in operating activitiesCurrentYearDuration_NonConsolidatedMember-1081129000JPY
Purchase of property plant and equipment inv cfPrior1YearDuration_NonConsolidatedMember-20764000JPY
Purchase of property plant and equipment inv cfCurrentYearDuration_NonConsolidatedMember-46262000JPY
Purchase of intangible assets inv cfPrior1YearDuration_NonConsolidatedMember-1680000JPY
Purchase of intangible assets inv cfCurrentYearDuration_NonConsolidatedMember－JPY
Purchase of investment securities inv cfPrior1YearDuration_NonConsolidatedMember－JPY
Purchase of investment securities inv cfCurrentYearDuration_NonConsolidatedMember-304720000JPY
Other net inv cfPrior1YearDuration_NonConsolidatedMember-420000JPY
Other net inv cfCurrentYearDuration_NonConsolidatedMember420000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-22864000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-350562000JPY
Repayment of long term loans payable fin cfPrior1YearDuration_NonConsolidatedMember-160008000JPY
Repayment of long term loans payable fin cfCurrentYearDuration_NonConsolidatedMember-160008000JPY
Proceeds from issuance of common stock fin cfPrior1YearDuration_NonConsolidatedMember199929000JPY
Proceeds from issuance of common stock fin cfCurrentYearDuration_NonConsolidatedMember3616623000JPY
Net decrease increase in restricted deposits fin cfPrior1YearDuration_NonConsolidatedMember-372324000JPY
Net decrease increase in restricted deposits fin cfCurrentYearDuration_NonConsolidatedMember372625000JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember-332402000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember3829240000JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-1128077000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember2397549000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember1966030000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember837952000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember837952000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember3235502000JPY
Write downs of inventoriesPrior1YearDuration_NonConsolidatedMember－JPY
Write downs of inventoriesCurrentYearDuration_NonConsolidatedMember4000000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember193775000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember194299000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember5815000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember6150000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember16534000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember16631000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember307545000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember255208000JPY
Business consignment expenses sgaPrior1YearDuration_NonConsolidatedMember91507000JPY
Business consignment expenses sgaCurrentYearDuration_NonConsolidatedMember95395000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodPrior1YearDuration_NonConsolidatedMember307545000JPY
Research and development expenses included in general and administrative expenses and manufacturing cost for current periodCurrentYearDuration_NonConsolidatedMember255208000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)近畿財務局長
Filing date cover pageFilingDateInstant2022-06-30
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第15期（自　2021年４月１日　至　2022年３月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)ステラファーマ株式会社
Company name in english cover pageFilingDateInstantSTELLA PHARMA CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　上原　幸樹
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)大阪市中央区高麗橋三丁目２番７号　ＯＲＩＸ高麗橋ビル
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)(06)4707-1516（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員総務部長　小川　礼隆

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · operating cash flownon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flownon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass